Injective is making significant strides in the cryptocurrency market with plans to launch a layer-3 network on Arbitrum, aiming to enhance its blockchain capabilities within the Ethereum ecosystem. This expansion follows a year of volatility for its INJ token, which saw a dramatic rise and subsequent decline. Additionally, Injective is capitalizing on the emerging ERC-404 standard to enable fractional NFT ownership, broadening its appeal and potential use cases in the financial sector.
The company is also innovating in the derivatives space by introducing onchain pre-IPO perpetuals, offering investors decentralized alternatives to traditional equity tokens. Meanwhile, the filing of a staked Injective ETF by Canary Capital and the establishment of a $100 million Injective treasury by Pineapple highlight growing institutional interest and confidence in Injective's potential. These developments collectively underscore Injective's strategic efforts to diversify its offerings and strengthen its position in the evolving crypto landscape.
Injective (INJ): Pioneering Blockchain Expansion Amid Market Volatility
October 17, 2025
1 min read
Injective is making significant strides in the cryptocurrency market with plans to launch a layer-3 network on Arbitrum, aiming to enhance its blockchain capabilities within the Ethereum ecosystem. This expansion follows a year of volatility for its INJ token, which saw a dramatic rise and subsequent decline. Additionally, Injective is capitalizing on the emerging ERC-404 standard to enable fractional NFT ownership, broadening its appeal and potential use cases in the financial sector.